卡巴化单体过敏剂用于儿科呼吸道过敏的子语言免疫疗法
Chang-Keun Kim1, Enrico Compalati2, Zak Callaway1,3
1Asthma & Allergy Center, Inje University Sanggye Paik Hospital, Seoul, Korea.
Asia Pacific allergy
|July 31, 2025
概括
碳化单体过敏剂 (CMAs) 为患有过敏疾病的儿童提供安全有效的舌下免疫疗法 (SLIT). 这篇评论强调了它们对其他过敏性鼻炎和喘治疗方法的好处.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
- 儿科医学 儿科医学
背景情况:
- 过敏原免疫疗法 (AIT) 是对过敏性疾病的因果治疗,针对病理生理学.
- 碳amylated单体过敏剂 (CMAs) 是改性过敏原,其过敏性降低,但免疫性保留.
- 由于其小尺寸和安全性,CMAs适合进行语言下免疫疗法 (SLIT).
研究的目的:
- 审查儿童中基于CMA的SLIT的疗效,安全性和临床应用.
- 评估CMA-SLIT作为皮下免疫治疗的潜在替代方案.
主要方法:
- 对儿童过敏疾病的CMA-SLIT现有文献的审查.
- 对安全性,有效性和合规性数据的分析.
主要成果:
- CMAs提供了诸如增强的粘膜吸收,抗降解和改善生物可用性等优势.
- 降低过敏性可确保安全性和耐受性,对于儿科患者来说至关重要.
- 药片配方方便于准确的剂量和监测患者的遵守.
结论:
- CMA-SLIT是一种有前途,安全和有效的治疗选择,用于儿科过敏性鼻炎和喘.
- 它的有利特性使其成为传统皮下免疫疗法的可行替代方案.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
464
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
464
Antiasthma Drugs: Leukotriene Modifiers
482
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
482
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
589
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
589
Allergic Reactions
28.7K
Overview
28.7K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
397
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
397


